Displaying drugs 51 - 75 of 403 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Basiliximab | 143801.3 C6378H9844N1698O1997S48 |  | A monoclonal anti-C25 antibody (interleukin-2 receptor alpha subunit) used as immunosuppressive therapy in kidney transplant patients. | Interleukin Inhibitors |
| Becaplermin | 12294.4 C532H892N162O153S9 |  | A recombinant form of human platelet-derived growth factor used to treat ulcers due to diabetic neuropathy in the lower extremities when there is adequate blood supply to the area. | Angiogenesis Inducing Agents / DNA-Binding Proteins / Human Platelet-derived Growth Factor / Platelet-Derived Growth Factor / Proto-Oncogene Proteins / Proto-Oncogene Proteins c-sis |
| Belantamab mafodotin | Not Available |  | An anti B-cell maturation antigen antibody conjugated to a microtubule inhibitor to treat relapsed or refractory multiple myeloma. | Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Antibodies, Monoclonal, Humanized / Antibody-drug Conjugates / Antineoplastic Agents / Antineoplastic and Immunomodulating Agents / Blood Proteins / BSEP/ABCB11 Substrates / Cancer immunotherapy / Globulins / Immunoglobulins / Immunoproteins / Immunotherapy / MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES / OATP1B1/SLCO1B1 Substrates / OATP1B3 substrates / P-glycoprotein substrates / Proteins / Serum Globulins / Tubulin Inhibiting Agent |
| Belatacept | 92300.0 C3508H5440N922O1096S32 | | A selective T-cell costimulation blocker used in the prophylaxis of organ rejection in adult patients receiving a kidney transplant. | Selective Immunosuppressants |
| Belimumab | 147000.0 C6358H9904N1728O2010S44 |  | A B-lymphocyte stimulator (BLyS)-specific inhibitor used to treat systemic lupus erythematosus and active lupus nephritis as an add-on therapy. | Selective Immunosuppressants |
| Benralizumab | 146054.0 C6492H10060N1724O2028S42 |  | A monoclonal antibody used to treat eosinophilic asthma. | Anti-Asthmatic Agents / Interleukin-5 Receptor alpha-directed Cytolytic Antibody |
| Beractant | Not Available | | A pulmonary surfactant used for the treatment and prevention of Respiratory Distress Syndrome (RDS) in premature infants. | Pulmonary Surfactants / Surface-Active Agents |
| Beroctocog alfa | Not Annotated | | Beroctocog alfa is indicated for the prevention and control of bleeding in patients with hemophilia A or acquired Factor VIII (FVIII) deficiency. It is also indicated for surgical/invasive procedures in... | Blood Coagulation Factors / Coagulants / Factor VIII / Human Antihemophilic Factors / Protein Precursors |
| Besilesomab | Not Available |  | A monoclonal antibody bound to technetium-99 used to find infection and inflammation in patients with suspected osteomyelitis. | Radiopharmaceuticals |
| Bevacizumab | 149000.0 C6538H10034N1716O2033S44 |  | A monoclonal anti-vascular endothelial growth factor antibody used in combination with antineoplastic agents for the treatment of many types of cancer. | Antibodies, Monoclonal / Antineovascularisation Agents / VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors |
| Bezlotoxumab | 148200.0 C6464H9974N1726O2014S46 | | A monoclonal antibody used to reduce the recurrence of Clostridium difficile infections. | Antibacterial monoclonal antibodies / Specific Immunoglobulins |
| Bimekizumab | C6552H10132N1750O2029S42 | | An anti-IL-17A, IL-17F, and IL-17AF monoclonal antibody used in the treatment plaque psoriasis. | Interleukin Inhibitors |
| Black widow spider antivenin (equine) | Not Annotated | | Black widow spider (Latrodectus mactans) antivenin is a treatment for black widow spider bites derived from the serum of healthy horses immunized against black widow spider venom. | Antivenins |
| Blinatumomab | 54100.0 C2367H3577N649O772S19 |  | An antineoplastic antibody used to treat CD19-positive B-cell precursor acute lymphoblastic leukemia (ALL) in relapsed and refractory patients, as well as those in first or second complete remission with minimal residual disease (MRD). | Antibodies, Monoclonal |
| Botulinum toxin type A | 900000.0 C6760H10447N1743O2010S32 |  | A purified form of botulinum toxin type A used to block acetylcholine release in the treatment of chronic sialorrhea, muscle spasticity, and dystonia, as well as in cosmetic applications. | Acetylcholine Release Inhibitors / Botulinum Toxins / Botulinum Toxins, Type A / Neuromuscular Agents / Neuromuscular Blocking Agents / Neurotoxins |
| Botulinum toxin type B | 150804.0 |  | A purified form of botulinum toxin type B used to block acetylcholine release in the treatment of cervical dystonia and sialorrhea. | Acetylcholine Release Inhibitors / Anti-Dyskinesia Agents / Neurotoxins |
| Bovine type I collagen | Not Available | | A collagen gel derived from cows used to treat a wide variety of wounds, as well as a supplement for bones and joints. | Allogeneic Cultured Cell Scaffold |
| Bremelanotide | Not Available | | Bremelanotide is indicated to treat premenopausal women with hypoactive sexual desire disorder that is not due to a medical or psychiatric condition, problems with the relationship, or the effects of... | Receptor, Melanocortin, Type 3, agonists / Receptor, Melanocortin, Type 4, agonists |
| Brentuximab vedotin | 150500.0 C6476H9930N1690O2030S40 |  | A CD30-directed antibody-drug conjugate used to treat various types of lymphoma. | Antibodies, Monoclonal |
| Brodalumab | Not Available | | A monoclonal antibody used to treat moderate to severe plaque psoriasis. | Interleukin Inhibitors |
| Brolucizumab | 26000.0 | | An anti VEGF-A monoclonal antibody indicated to treat neovascular age related macular degeneration. | Antineovascularisation Agents |
| Bulevirtide | Not Available | | A drug for the treatment of chronic Hepatitis D infection in adults with compensated liver disease. | Amino Acids, Peptides, and Proteins / Antiinfectives for Systemic Use / Antiviral Agents / Antivirals for Systemic Use / Direct Acting Antivirals / Lipids / Peptides |
| Burosumab | 144100.0 C6388H9904N1700O2006S46 | | A fibroblast growth factor 23 blocking antibody used to treat X-linked hypophosphatemia. | Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Blood Proteins / Drugs Affecting Bone Structure and Mineralization / Drugs for Treatment of Bone Diseases / Fibroblast Growth Factor-23 Blocking Antibodies / Globulins / Immunoglobulins / Immunoproteins / Musculo-Skeletal System / Proteins / Serum Globulins |
| Canakinumab | 145157.0 C6452H9958N1722O2010S42 |  | An interleukin-1β blocker used to treat Periodic Fever Syndromes such as Cryopyrin-Associated Periodic Syndromes (CAPS) and Familial Mediterranean Fever (FMF), and also to treat active Systemic Juvenile Idiopathic Arthritis (SJIA). | Interleukin Inhibitors |
| Caplacizumab | 27880.0 C1213H1891N357O380S10 |  | A von Willebrand factor (vWF)-directed antibody fragment used to treat acquired thrombotic thrombocytopenic purpura (aTTP). | von Willebrand Factor, antagonists & inhibitors |
Displaying drugs 51 - 75 of 403 in total